Today’s monolithic silicon array detector for small field dosimetry: the Octa

Evaluation and Comparison of Dosimetric Characteristics of Semiflex®3D and Microdiamond in Relative Dosimetry under 6 and 15 MV Photon Beams in Small Fields

BACKGROUND

In modern radiotherapy techniques, the frequently small and non-uniformed fields can increase treatment efficiency due to their highly conformal dose distribution. Particular features including lack of Lateral Charge Particle Equilibrium (LCPE) lead to detectors with high resolution since any error in obtained dosimetric data could cause patient mistreatments.

OBJECTIVE

This study aims to evaluate and compare two small detectors (Semiflex^®3D and microdiamond) dosimetric characteristics in small field relative dosimetry.

MATERIAL AND METHODS

In this experimental study, the dosimetric properties of Semiflex^®3D and microdiamond were assessed under 6 and 15 MV photon beams. The linearity and stability of the detector's response and dose rate were measured. Square-field sizes ranging from 0.6×0.6 - 5×5 cm² were used for obtaining percentage depth dose curves (PDDs) and in-plane profiles. The angular and temperature dependence of both detectors' responses were also studied.

RESULTS

The detector response shows good stability, no deviation from linearity, and low dose rate dependence (≤1.6%). PDDs and in-plan profiles of both detectors are in good agreement and no significant difference was observed except for the high dose gradient regions (P-value≤0.017). Both detectors demonstrated low angular dependence (<0.3%) with temperature dependence lower than 1% for both detectors.

CONCLUSION

The results indicate both investigated detectors were well performed in small field relative dosimetry and for measuring penumbra, it is better to use microdiamond detector.

The dose magnifying glass quality assurance system for daily proton therapy range verification

Proton therapy has a distinct dosimetric advantage over conventional photon therapy due to its Bragg peak profile. This allows greater accuracy in dose delivery and dose conformation to the target, however it requires greater precision in setup, delivery and for quality assurance (QA) procedures. The AAPM TG 224 report recommends daily range and spot position checks with tolerance on the order of a millimetre. Daily QA systems must therefore be efficient for daily use and be capable of sub-millimetre precision however few suitable commercial systems are available. In this work, a compact, real-time daily QA system is optimised and characterised for proton range verification using an ad-hoc Geant4 simulation. The system is comprised of a monolithic silicon diode array detector embedded in a perspex phantom. The detector is orientated at an angular offset to the incident proton beam to allow range in perspex to be determined for flat proton fields. The accuracy of the system for proton range in perspex measurements was experimentally evaluated over the full range of clinical proton energies. The meanR₁₀₀,R₉₀andR₈₀ranges measured with the system were accurate within ±0.6 mm of simulated ranges in a perspex phantom for all energies assessed. This system allows real-time read-out of individual detector channels also making it appropriate for temporal beam delivery diagnostics and for spot position monitoring along one axis. The system presented provides a suitable, economical and efficient alternative for daily QA in proton therapy.